Evidence map›Paper›PMID 23719549›Full record

ArticleThe American journal of clinical nutrition2013

Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans.

Junhai Ou, Franck Carbonero, Erwin G Zoetendal, James P DeLany, Mei Wang, Keith Newton, H Rex Gaskins, Stephen J D O'Keefe

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The American journal of clinical nutrition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03028831 (Randomized Controlled Trial of Resistant Starch to Reduce Colon Cancer Risk in Alaska Native People.), which is not on this map. Cited by 320 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
320citing papers in PubMed, 6 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03028831 nacompletednot on this mapstarted 2017, after this paper: background citation

Randomized Controlled Trial of Resistant Starch to Reduce Colon Cancer Risk in Alaska Native People.

TypeinterventionalSponsorUniversity of PittsburghRan2017 to 2022Enrolled48ConditionsColon CancerArms70g of fully digestible starch amylopectin corn starch, Resistant starch
3 · Its place in the literature

Who cites it

320 citing papers in PubMed, 6 syntheses or guidelines pooled it, 643 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Therapeutic Evaluation ofNutrients · 2024
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

260 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Junhai OuDepartment of Gastroenterology, Hepatology and Nutrition, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Franck Carbonero
Erwin G Zoetendal
James P DeLany
Mei Wang
Keith Newton
H Rex Gaskins
Stephen J D O'Keefe
University of Pittsburgh · USChancellor University · USUniversity of Illinois Urbana-Champaign · USUniversity of KwaZulu-Natal · ZAWageningen University & Research · NL

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Diet and Gastrointestinal Cancer Risk in African Americans and Rural AfricansR01CA135379 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI O'KEEFE, STEPHEN J.D. · 2009 to 2012
$2.1M
NCATS NIH HHS UL1 TR000005NCI NIH HHS CA-135379
6 · The paper itself

Abstract

backgroundEpidemiologic studies have suggested that most cases of sporadic colon cancer can be attributed to diet. The recognition that colonic microbiota have a major influence on colonic health suggests that they might mediate colonic carcinogenesis.

objectiveTo examine the hypothesis that the influence of diet on colon cancer risk is mediated by the microbiota through their metabolites, we measured differences in colonic microbes and their metabolites in African Americans with a high risk and in rural native Africans with a low risk of colon cancer.

designFresh fecal samples were collected from 12 healthy African Americans aged 50-65 y and from 12 age- and sex-matched native Africans. Microbiomes were analyzed with 16S ribosomal RNA gene pyrosequencing together with quantitative polymerase chain reaction of the major fermentative, butyrate-producing, and bile acid-deconjugating bacteria. Fecal short-chain fatty acids were measured by gas chromatography and bile acids by liquid chromatography-mass spectrometry.

resultsMicrobial composition was fundamentally different, with a predominance of Prevotella in native Africans (enterotype 2) and of Bacteroides in African Americans (enterotype 1). Total bacteria and major butyrate-producing groups were significantly more abundant in fecal samples from native Africans. Microbial genes encoding for secondary bile acid production were more abundant in African Americans, whereas those encoding for methanogenesis and hydrogen sulfide production were higher in native Africans. Fecal secondary bile acid concentrations were higher in African Americans, whereas short-chain fatty acids were higher in native Africans.

conclusionOur results support the hypothesis that colon cancer risk is influenced by the balance between microbial production of health-promoting metabolites such as butyrate and potentially carcinogenic metabolites such as secondary bile acids.

Indexed as

DietMetagenomeAgedBile Acids and SaltsBlack or African AmericanBlack PeopleButyratesCarcinogensChromatography, GasChromatography, LiquidColonColonic NeoplasmsDNA, BacterialFatty Acids, VolatileFecesFemaleBile Acids and SaltsButyratesCarcinogensDNA, BacterialFatty Acids, VolatileRNA, Ribosomal, 16S

Identifiers

PMID23719549
PMCPMC3683814
OpenAlexW2137090067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.